C. Difficile

Clinical Trial Info

  • Category

    Current Enrolling Clinical Trials

C.  DIFF According to the CDC


Clostridioides difficile (also known as C. diff or CDIFF) is a bacterium that causes diarrhea and colitis (an inflammation of the colon).

It’s estimated to cause almost half a million illnesses in the United States each year.

About 1 in 6 patients who get C. diff will get it again in the subsequent 2-8 weeks.

Within a month of diagnosis, 1 in 11 people over age 65 died of a healthcare-associated C. diff infection.

PRISM-EXT: An Open-Label Extension of CP101 Trial Evaluating Oral FullSpectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection


Contact Research

 

Physician Investigator
Photo of Bharat K Misra M.D.
Gastroenterologist and Research Director Encore Borland Groover Clinical Research (EBGCR)
Clinical Research Location 4800 Belfort Road Jacksonville FL 32256 Contact Research: 9046800871
Return to top.